...
首页> 外文期刊>Cell death & disease. >Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development
【24h】

Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development

机译:细胞周期的化学解剖:细胞生物学和抗癌药物开发的探针

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Cancer cell proliferation relies on the ability of cancer cells to grow, transition through the cell cycle, and divide. To identify novel chemical probes for dissecting the mechanisms governing cell cycle progression and cell division, and for developing new anti-cancer therapeutics, we developed and performed a novel cancer cell-based high-throughput chemical screen for cell cycle modulators. This approach identified novel G1, S, G2, and M-phase specific inhibitors with drug-like properties and diverse chemotypes likely targeting a broad array of processes. We further characterized the M-phase inhibitors and highlight the most potent M-phase inhibitor MI-181, which targets tubulin, inhibits tubulin polymerization, activates the spindle assembly checkpoint, arrests cells in mitosis, and triggers a fast apoptotic cell death. Importantly, MI-181 has broad anti-cancer activity, especially against BRAF V600E melanomas.
机译:癌细胞增殖依赖于癌细胞生长,在细胞周期中过渡和分裂的能力。为了确定新的化学探针,以剖析控制细胞周期进程和细胞分裂的机制,并开发新的抗癌疗法,我们开发并进行了针对细胞周期调节剂的新型基于癌细胞的高通量化学筛选。该方法确定了具有药物样特性和可能针对广泛过程的不同化学型的新型G1,S,G2和M期特异性抑制剂。我们进一步表征了M期抑制剂,并重点介绍了最有效的M期抑制剂MI-181,其靶向微管蛋白,抑制微管蛋白聚合,激活纺锤体装配检查点,将细胞停在有丝分裂中并触发快速凋亡的细胞死亡。重要的是,MI-181具有广泛的抗癌活性,尤其是针对BRAF V600E 黑色素瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号